Pr
Princess Margaret
NPToronto CAFounded 19524,000 employees
Private CapacadPrivateOncology
Platform: Cancer Center
Market Cap
N/A
All Drugs
5
Clinical Trials
5
Failed / Terminated
1
FDA Approved
0
Drug Pipeline (5 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| PRI-IIT-139 | PRI-IIT-139 | Preclinical | 1 | FcRn | MCC | ||
| PRI-IIT-117 | PRI-IIT-117 | Preclinical | 1 | MALT1 | Bladder Ca | ||
| PRI-IIT-560 | PRI-IIT-560 | Phase 1/2 | 1 | KRASG12D | TTR Amyloidosis | ||
| PRI-IIT-296 | PRI-IIT-296 | NDA/BLA | 1 | EZH2 | SCD | ||
| PRI-IIT-807 | PRI-IIT-807 | Phase 2/3 | 1 | CD47 | IPF |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (4)